Research articlePublished 2016

Dengue Fever Associated Liver Failure

Authors: Joanne Mui Ching Tan, Natalie Woon Hui Tan, Koh Cheng Thoon, Chia Yin Chong, Christina Ong

Pediatric Infectious Diseases: Open Access

Volume 1 · Issue 4 · Pages 31

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Dengue fever is common in Southeast Asia although liver failure is a rare complication with up to 50% mortality rate reported in children. Objective: To evaluate the characteristics and treatment outcome of dengue fever associated liver failure (DFALF) in a case series of 4 paediatric patients. DFALF was defined as INR>2, regardless of the presence or absence of encephalopathy or INR>1.5 not corrected by Vitamin K in the presence of clinical hepatic encephalopathy, during the course of concurrent dengue infection. Material and methods: Patients with DFALF, admitted to a tertiary paediatric centre in Singapore over a 6 year period (January 2009-December 2015) were identified from the Gastroenterology and Infectious Disease databases. Case records were retrospectively reviewed. Results: Four patients, all boys, age 5 months to 6 years, presented at the acute febrile phase of illness with Dengue Shock Syndrome (severe dengue). Aspartate Transaminase (AST) and Alanine Transaminase (ALT) peaked at day 4-7: median (± 2SD) peak ALT 1871.5 ± 917 u/L, whereas median peak AST 7802.5 ± 5453.8 u/L. Median peak International Normalised Ratio ( INR ), ammonia, lactate were 2.9 ± 1.6, 106 ± 144.6 umol/L, and 7.4 ± 8.4 mmol/L respectively. All patients had hepatomegaly and mild conjugated hyperbilirubinaemia, with median peak total bilirubin 73.5 ± 36.9 umol/L. Two patients received N-Acetylcysteine. One patient received intravenous dexamethasone for dengue associated hemophagocytic lymphohistiocytosis. All recovered fully with supportive treatment based on a well-designed acute liver failure protocol, which comprised of intensive care monitoring, correction of coagulopathy and hypoglycaemia, empirical broad spectrum antibiotic coverage and anti-fungal prophylaxis, gastrointestinal haemorrhage prophylaxis with a histamine-2 receptor antagonist, proton pump inhibitor or sucralfate, and lactulose to reduce hyperammonaemia. Liver function significantly improved (ALT<500 u/L) at a median of 6.5 ± 2 days from onset of liver failure. INR normalized (INR<1.1) at a median of 13.5 ± 6 days of illness. Conclusion: Patients with DFALF can achieve normalisation of liver function and full recovery with early supportive treatment.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.

Try:

More from this journal

The newest in Pediatric Infectious Diseases: Open Access.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPediatric Infectious Diseases: Open Access
  • SubjectInfectious Diseases
  • SubjectPaediatrics & Neonatology
  • BylineArticles whose byline prints “Joanne Mui Ching Tan”
  • BylineArticles whose byline prints “Natalie Woon Hui Tan”
  • BylineArticles whose byline prints “Koh Cheng Thoon”
  • BylineArticles whose byline prints “Chia Yin Chong”
  • BylineArticles whose byline prints “Christina Ong”